Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
20 | 51524725 | intron variant | T/C | snv | 5.7E-02 |
|
Immune System Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
1.000 | 0.080 | 20 | 51492442 | intron variant | G/A | snv | 0.65 |
|
0.700 | 1.000 | 3 | 2018 | 2019 | ||||||||
|
0.925 | 0.080 | 20 | 51538108 | intron variant | T/G | snv | 0.18 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2018 | 2019 | |||||||
|
0.925 | 0.080 | 20 | 51538108 | intron variant | T/G | snv | 0.18 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.040 | 20 | 51519305 | intron variant | C/T | snv | 4.1E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 20 | 51519305 | intron variant | C/T | snv | 4.1E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
20 | 51513177 | intron variant | T/C | snv | 5.1E-02 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
20 | 51522481 | intron variant | C/A;G | snv |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.040 | 20 | 51467037 | intron variant | A/G | snv | 1.2E-03 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.120 | 20 | 51541298 | intron variant | A/G | snv | 0.17 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.120 | 20 | 51541298 | intron variant | A/G | snv | 0.17 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
20 | 51536805 | intron variant | T/C | snv | 0.68 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 20 | 51392255 | intron variant | C/T | snv | 0.43 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 51549095 | intron variant | C/G;T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 20 | 51549095 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.851 | 0.120 | 20 | 51419700 | intron variant | A/T | snv | 4.9E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 20 | 51492442 | intron variant | G/A | snv | 0.65 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 20 | 51492442 | intron variant | G/A | snv | 0.65 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 20 | 51492442 | intron variant | G/A | snv | 0.65 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 20 | 51492442 | intron variant | G/A | snv | 0.65 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
20 | 51518144 | intron variant | A/G | snv | 6.1E-02 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
20 | 51524602 | intron variant | T/C | snv | 5.8E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
20 | 51524602 | intron variant | T/C | snv | 5.8E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
20 | 51524602 | intron variant | T/C | snv | 5.8E-02 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
1.000 | 0.080 | 20 | 51538847 | intron variant | T/C | snv | 0.70 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 |